Cargando…

Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals

Background. Recently, several studies suggest that galectin-9 (Gal-9) might play a pivotal role in the pathogenesis of autoimmune diseases. However, the exact role of Gal-9 in atherosclerosis remains to be elucidated. Methods. Serum Gal-9, high-sensitivity C-reactive protein (hs-CRP), interferon- (I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Ruirui, Liu, Cheng, Tang, Hongxia, Zeng, Qiutang, Wang, Xiang, Zhu, Zhengfeng, Liu, Yuzhou, Mao, Xiaobo, Zhong, Yucheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667018/ https://www.ncbi.nlm.nih.gov/pubmed/26663989 http://dx.doi.org/10.1155/2015/457167

Ejemplares similares

Galectin-9: A Suppressor of Atherosclerosis?
por: Yu, Jian, et al.
Publicado: (2020)

Corrigendum: Galectin-9: A Suppressor of Atherosclerosis?
por: Yu, Jian, et al.
Publicado: (2021)

Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin
por: Zhong, Yucheng, et al.
Publicado: (2012)

Lanatoside C Promotes Foam Cell Formation and Atherosclerosis
por: Shi, Huairui, et al.
Publicado: (2016)

Interleukin-27 Ameliorates Atherosclerosis in ApoE(−/−) Mice through Regulatory T Cell Augmentation and Dendritic Cell Tolerance
por: Xu, Wenbin, et al.
Publicado: (2022)

Role of IL-37- and IL-37-Treated Dendritic Cells in Acute Coronary Syndrome
por: Zhu, Ruirui, et al.
Publicado: (2021)

Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
por: Zhu, Ruirui, et al.
Publicado: (2016)

IL-37 Plays a Beneficial Role in Patients with Acute Coronary Syndrome
por: Mao, Xiaobo, et al.
Publicado: (2019)

Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP
por: Zhao, Xiaoqi, et al.
Publicado: (2015)

GARP and GARP-Treated tDC Prevented the Formation of Atherosclerotic Plaques in ApoE(−/-) Mice
por: Cai, Yifan, et al.
Publicado: (2021)

Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke
por: He, Xin-Wei, et al.
Publicado: (2017)

Serum Galectin-9 and Galectin-3-Binding Protein in Acute Dengue Virus Infection
por: Liu, Kuan-Ting, et al.
Publicado: (2016)

Thymic Stromal Lymphopoietin Attenuates the Development of Atherosclerosis in ApoE(−/−) Mice
por: Yu, Kunwu, et al.
Publicado: (2013)

Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
por: Wei, Yuzhen, et al.
Publicado: (2019)

A Potential Mechanism of High-Dose Ticagrelor in Modulating Platelet Activity and Atherosclerosis Mediated by Thymic Stromal Lymphopoietin Receptor
por: Mao, Yi, et al.
Publicado: (2015)

Serum Galectin-3 Predicts Mortality in Venoarterial Extracorporeal Membrane Oxygenation Patients
por: Zhu, Jianlong, et al.
Publicado: (2023)

Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis
por: Matsuoka, Naoki, et al.
Publicado: (2019)

Effects of IL-38 on Macrophages and Myocardial Ischemic Injury
por: Li, Zhiyang, et al.
Publicado: (2022)

Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels
por: Seifert, Adrian M., et al.
Publicado: (2020)

Expression and Significance of Galectin-1 and Galectin-3 in the Serum and Placental Tissues of Patients with Intrahepatic Cholestasis of Pregnancy
por: Qian, Li-Hua, et al.
Publicado: (2023)

Galectin-1 and Galectin-9 Concentration in Maternal Serum: Implications in Pregnancies Complicated with Preterm Prelabor Rupture of Membranes
por: Boroń, Dorota Grażyna, et al.
Publicado: (2022)

Elevated Plasma IL-38 Concentrations in Patients with Acute ST-Segment Elevation Myocardial Infarction and Their Dynamics after Reperfusion Treatment
por: Zhong, Yucheng, et al.
Publicado: (2015)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Increased serum levels of Galectin-9 in patients with chronic lymphocytic leukemia
por: Wdowiak, Kamil, et al.
Publicado: (2019)

Pattern Analysis of Serum Galectins-1, -3, and -9 in Breast Cancer
por: Funkhouser, Avery, et al.
Publicado: (2023)

Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death
por: Yang, Riyao, et al.
Publicado: (2022)

Galectin-9 in Gastroenterological Cancer
por: Morishita, Asahiro, et al.
Publicado: (2023)

Association Between Serum Galectin-3 Levels and Coronary Stenosis Severity in Patients With Coronary Artery Disease
por: Li, Mingxing, et al.
Publicado: (2022)

Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice
por: Ji, Qingwei, et al.
Publicado: (2017)

Targeting the CD146/Galectin-9 axis protects the integrity of the blood–brain barrier in experimental cerebral malaria
por: Duan, Hongxia, et al.
Publicado: (2020)

Galectins and galectin-mediated autophagy regulation: new insights into targeted cancer therapy
por: Liu, Dan, et al.
Publicado: (2023)

Serum CTRP9 Reflects Coronary Collateralization in Nondiabetic Patients with Obstructive Coronary Artery Disease
por: Gao, Ang, et al.
Publicado: (2022)

Serum Galectin-3 level, not Galectin-1, is associated with the clinical feature and outcome in patients with acute ischemic stroke
por: Dong, Han, et al.
Publicado: (2017)

Prevalence and prognosis of molecularly defined familial hypercholesterolemia in patients with acute coronary syndrome
por: Wang, Cheng, et al.
Publicado: (2022)

The role of salivary galectin-3 and galectin-9 levels in plaque-induced gingivitis and periodontitis
por: Barut, Zerrin, et al.
Publicado: (2023)

Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease
por: Kurose, Yuko, et al.
Publicado: (2013)

Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis
por: Chihara, Mami, et al.
Publicado: (2018)

Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages
por: Reyes-Vallejo, Tania, et al.
Publicado: (2022)

Sensing of mycobacterial arabinogalactan by galectin‐9 exacerbates mycobacterial infection
por: Wu, Xiangyang, et al.
Publicado: (2021)

Serum galectin-3BP as a novel marker of obesity and metabolic syndrome in Chinese adolescents
por: Zhen, Shihan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qmis7ftfl48av186u5n1d5n7e2